Literature DB >> 28124627

Understanding the low uptake of bone-anchored hearing aids: a review.

R Powell1, A Wearden1, S M Pardesi1, K Green2.   

Abstract

BACKGROUND: Bone-anchored hearing aids improve hearing for patients for whom conventional behind-the-ear aids are problematic. However, uptake of bone-anchored hearing aids is low and it is important to understand why this is the case.
METHOD: A narrative review was conducted. Studies examining why people accept or decline bone-anchored hearing aids and satisfaction levels of people with bone-anchored hearing aids were reviewed.
RESULTS: Reasons for declining bone-anchored hearing aids included limited perceived benefits, concerns about surgery, aesthetic concerns and treatment cost. No studies providing in-depth analysis of the reasons for declining or accepting bone-anchored hearing aids were identified. Studies of patient satisfaction showed that most participants reported benefits with bone-anchored hearing aids. However, most studies used cross-sectional and/or retrospective designs and only included people with bone-anchored hearing aids.
CONCLUSION: Important avenues for further research are in-depth qualitative research designed to fully understand the decision-making process for bone-anchored hearing aids and rigorous quantitative research comparing satisfaction of people who receive bone-anchored hearing aids with those who receive alternative (or no) treatments.

Entities:  

Keywords:  Bone-Anchored Hearing Aids; Correction of Hearing Impairment; Decision Making; Hearing Aids; Hearing Loss; Patient Satisfaction

Mesh:

Year:  2017        PMID: 28124627     DOI: 10.1017/S0022215116009981

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  Speech Understanding and Sound Localization with a New Nonimplantable Wearing Option for Baha.

Authors:  Tom Gawliczek; Wilhelm Wimmer; Fabio Munzinger; Marco Caversaccio; Martin Kompis
Journal:  Biomed Res Int       Date:  2018-09-25       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.